Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STK4 | Q13043 | 12/20 | 0.84 |
| ▸ | STK3 | Q13188 | 1/20 | 0.65 |
| ▸ | EGFR | P00533 | 7/20 | 0.64 |
| ▸ | ERBB2 | P04626 | 6/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28503961 | 0.95 | STK4 (0.81) | STK4STK3EGFRERBB2 | |
| SCHEMBL30390074 | 0.95 | STK4 (0.81) | STK4STK3EGFRERBB2 | |
| SCHEMBL29670931 | 0.95 | STK4 (0.81) | STK4STK3EGFRERBB2 | |
| Hydrochloric Acid SCHEMBL28499414 | 0.94 | STK4 (0.80) | STK4STK3EGFRERBB2 | |
| Hydrochloric Acid SCHEMBL29670929 | 0.94 | STK4 (0.80) | STK4STK3EGFRERBB2 | |
| SCHEMBL22419632 | 0.91 | STK4 (1.00) | STK4STK3EGFRERBB2 | |
| SCHEMBL18343640 | 0.91 | STK4 (1.00) | STK4STK3EGFRERBB2 | |
| SCHEMBL22419670 | 0.90 | STK4 (0.82) | STK4STK3EGFRERBB2 | |
| SCHEMBL22419797 | 0.90 | STK4 (0.82) | STK4STK3EGFRERBB2 | |
| SCHEMBL22419631 | 0.90 | STK4 (1.00) | STK4STK3EGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11427560-B2 | Composition and methods for inhibiting mammalian sterile 20-like kinase 1 | THE SCRIPPS RESEARCH INSTITUTE (US) | 2022-08-30 | — | — | US | disclosed |
| US-20210061784-A1 | COMPOSITION AND METHODS FOR INHIBITING MAMMALIAN STERILE 20-LIKE KINASE 1 | UNIVERSITÄT BREMEN (DE) | 2021-03-04 | — | — | US | disclosed |
| US-10774068-B2 | Composition and methods for inhibiting mammalian sterile 20-like kinase 1 | THE SCRIPPS RESEARCH INSTITUTE (US) | 2020-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210061784-A1 | COMPOSITION AND METHODS FOR INHIBITING MAMMALIAN STERILE 20-LIKE KINASE 1 | TESK2, TESK1, PRKACB | STK4 852/4885STK3 456/4885EGFR 3953/4885 |
| US-11427560-B2 | Composition and methods for inhibiting mammalian sterile 20-like kinase 1 | TESK2, TESK1, PRKACB | STK4 852/4885STK3 456/4885EGFR 3953/4885 |
| US-10774068-B2 | Composition and methods for inhibiting mammalian sterile 20-like kinase 1 | TESK2, TESK1, PRKACB | STK4 852/4885STK3 456/4885EGFR 3953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.